Long-Term Outcome in Methylmalonic Acidurias Is Influenced by the Underlying Defect (mut0, mut−, cblA, cblB)-Reference-Cited by-同舟云学术

Long-Term Outcome in Methylmalonic Acidurias Is Influenced by the Underlying Defect (mut0, mut−, cblA, cblB)

Published:2007-08 Issue:2 Volume:62 Page:225-230
ISSN:0031-3998
Container-title:Pediatric Research
language:
Short-container-title:Pediatr Res

Author:

Hörster Friederike,Baumgartner Matthias R,Viardot Caroline,Suormala Terttu,Burgard Peter,Fowler Brian,Hoffmann Georg F,Garbade Sven F,Kölker Stefan,Baumgartner E Regula

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology, and Child Health

Reference26 articles.

1. Inherited Methylmalonyl CoA Mutase Apoenzyme Deficiency in Human Fibroblasts

2. The cblD Defect Causes Either Isolated or Combined Deficiency of Methylcobalamin and Adenosylcobalamin Synthesis

3. Nonlinear partial differential equations and applications: Identification of the gene responsible for the cblA complementation group of vitamin B12-responsive methylmalonic acidemia based on analysis of prokaryotic gene arrangements

4. Identification of the gene responsible for the cblB complementation group of vitamin B12-dependent methylmalonic aciduria

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved therapeutic efficacy in two mouse models of methylmalonic acidemia (MMA) using a second-generation mRNA therapy;Molecular Genetics and Metabolism;2024-09

2. Clinical practice recommendations on kidney management in methylmalonic acidemia: an expert consensus statement from ERKNet and MetabERN;Kidney International Reports;2024-09

3. Long‐Term Outcomes of Living Donor Liver Transplantation for Methylmalonic Acidemia;Pediatric Transplantation;2024-08-05

4. Renal Replacement Therapy in Methylmalonic Aciduria-Related Metabolic Failure: Case Report and Literature Review;Journal of Clinical Medicine;2024-07-23

5. An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom;Clinical Drug Investigation;2024-05-25